Given the key role of the NLRP3 inflammasome in the pathogenesis of neuropsychiatric disorders such as treatment-resistant depression, PTSD, bipolar disorder, or schizophrenia with an inflammatory component, its pharmacological and non-pharmacological inhibition represent a promising direction for targeted molecular therapy [60]. Here, NLRP3 is linked to post-traumatic stress disorder.